Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative
•Incidence of meningococcal disease is similar across the Asia–Pacific region.•The most prevalent serogroups of N. meningitidis are B, w and Y, with c also emerging.•Except for China and Australia, vaccination is not included in NIPs across the region.•Antibiotic resistance is an ongoing concern, wi...
Gespeichert in:
| Veröffentlicht in: | The Journal of infection 2020-11, Vol.81 (5), p.698-711 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 711 |
|---|---|
| container_issue | 5 |
| container_start_page | 698 |
| container_title | The Journal of infection |
| container_volume | 81 |
| creator | Aye, Aye Mya Min Bai, Xilian Borrow, Ray Bory, Sotharith Carlos, Josefina Caugant, Dominique A. Chiou, Chien-Shun Dai, Vo Thi Trang Dinleyici, Ener Cagri Ghimire, Prakash Handryastuti, Setyo Heo, Jung Yeon Jennison, Amy Kamiya, Hajime Tonnii Sia, Loong Lucidarme, Jay Marshall, Helen Putri, Nina Dwi Saha, Senjuti Shao, Zhujun Sim, James Heng Chiak Smith, Vinny Taha, Muhamed-Kheir Van Thanh, Phan Thisyakorn, Usa Tshering, Kinley Vázquez, Julio Veeraraghavan, Balaji Yezli, Saber Zhu, Bingqing |
| description | •Incidence of meningococcal disease is similar across the Asia–Pacific region.•The most prevalent serogroups of N. meningitidis are B, w and Y, with c also emerging.•Except for China and Australia, vaccination is not included in NIPs across the region.•Antibiotic resistance is an ongoing concern, with non-susceptible strains emerging.•A number of countries have adopted whole genome sequencing in surveillance programs.
The degree of surveillance data and control strategies for invasive meningococcal disease (IMD) varies across the Asia–Pacific region. IMD cases are often reported throughout the region, but the disease is not notifiable in some countries, including Myanmar, Bangladesh and Malaysia. Although there remains a paucity of data from many countries, specific nations have introduced additional surveillance measures. The incidence of IMD is low and similar across the represented countries ( |
| doi_str_mv | 10.1016/j.jinf.2020.07.025 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2429784540</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0163445320305065</els_id><sourcerecordid>2429784540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-b0cce10a7af237e4865decad3b416376a1242adb3210d5cdd3bd9ee7d28ee0b13</originalsourceid><addsrcrecordid>eNp9kM1O3DAUhS1UBAPlBbqosoRF0uufxJOqmxECWglEF7C2HPtmeqeZhNqZkdjxDn1DngRHQ5HYdOXF_c6xzsfYJw4FB159WRUr6ttCgIACdAGi3GMzXkqRC63EBzZLkMyVKuUhO4pxBQC1rKsDdiiFllDX9Yz9vsGe-uXgBudsl3mKaCNmcRO2SF1ne4cZ9dn4C7NFJPv89PenddSSywIuaeiz0-n7s6_ZXSKW3dCkkvW7SuppJDvSFj-y_dZ2EU9e32N2f3lxd_49v769-nG-uM6dqqoxb8A55GC1bYXUqOZV6dFZLxuV9ujKcqGE9Y0UHHzpfDr4GlF7MUeEhstjdrrrfQjDnw3G0awpOpzW4LCJJsVrPVelgoSKHerCEGPA1jwEWtvwaDiYSbJZmUmymVYa0CZJTqHPr_2bZo3-LfLPagK-7QBMK7eEwURHmFR6CuhG4wf6X_8L_wqPcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2429784540</pqid></control><display><type>article</type><title>Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Aye, Aye Mya Min ; Bai, Xilian ; Borrow, Ray ; Bory, Sotharith ; Carlos, Josefina ; Caugant, Dominique A. ; Chiou, Chien-Shun ; Dai, Vo Thi Trang ; Dinleyici, Ener Cagri ; Ghimire, Prakash ; Handryastuti, Setyo ; Heo, Jung Yeon ; Jennison, Amy ; Kamiya, Hajime ; Tonnii Sia, Loong ; Lucidarme, Jay ; Marshall, Helen ; Putri, Nina Dwi ; Saha, Senjuti ; Shao, Zhujun ; Sim, James Heng Chiak ; Smith, Vinny ; Taha, Muhamed-Kheir ; Van Thanh, Phan ; Thisyakorn, Usa ; Tshering, Kinley ; Vázquez, Julio ; Veeraraghavan, Balaji ; Yezli, Saber ; Zhu, Bingqing</creator><creatorcontrib>Aye, Aye Mya Min ; Bai, Xilian ; Borrow, Ray ; Bory, Sotharith ; Carlos, Josefina ; Caugant, Dominique A. ; Chiou, Chien-Shun ; Dai, Vo Thi Trang ; Dinleyici, Ener Cagri ; Ghimire, Prakash ; Handryastuti, Setyo ; Heo, Jung Yeon ; Jennison, Amy ; Kamiya, Hajime ; Tonnii Sia, Loong ; Lucidarme, Jay ; Marshall, Helen ; Putri, Nina Dwi ; Saha, Senjuti ; Shao, Zhujun ; Sim, James Heng Chiak ; Smith, Vinny ; Taha, Muhamed-Kheir ; Van Thanh, Phan ; Thisyakorn, Usa ; Tshering, Kinley ; Vázquez, Julio ; Veeraraghavan, Balaji ; Yezli, Saber ; Zhu, Bingqing</creatorcontrib><description>•Incidence of meningococcal disease is similar across the Asia–Pacific region.•The most prevalent serogroups of N. meningitidis are B, w and Y, with c also emerging.•Except for China and Australia, vaccination is not included in NIPs across the region.•Antibiotic resistance is an ongoing concern, with non-susceptible strains emerging.•A number of countries have adopted whole genome sequencing in surveillance programs.
The degree of surveillance data and control strategies for invasive meningococcal disease (IMD) varies across the Asia–Pacific region. IMD cases are often reported throughout the region, but the disease is not notifiable in some countries, including Myanmar, Bangladesh and Malaysia. Although there remains a paucity of data from many countries, specific nations have introduced additional surveillance measures. The incidence of IMD is low and similar across the represented countries (<0.2 cases per 100,000 persons per year), with the predominant serogroups of Neisseria meningitidis being B, W and Y, although serogroups A and X are present in some areas. Resistance to ciprofloxacin is also of concern, with the close monitoring of antibiotic-resistant clonal complexes (e.g., cc4821) being a priority. Meningococcal vaccination is only included in a few National Immunization Programs, but is recommended for high-risk groups, including travellers (such as pilgrims) and people with complement deficiencies or human immunodeficiency virus (HIV). Both polysaccharide and conjugate vaccines form part of recommendations. However, cost and misconceptions remain limiting factors in vaccine uptake, despite conjugate vaccines preventing the acquisition of carriage.</description><identifier>ISSN: 0163-4453</identifier><identifier>EISSN: 1532-2742</identifier><identifier>DOI: 10.1016/j.jinf.2020.07.025</identifier><identifier>PMID: 32730999</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antibiotic resistance ; Asia - epidemiology ; Asia-Pacific ; Bacterial meningitis ; Bangladesh ; Carriage ; Conjugate vaccine ; Emerging strains ; High-risk groups ; Humans ; Immunization program ; Meningococcal disease ; Meningococcal Infections - epidemiology ; Meningococcal Infections - prevention & control ; Meningococcal Vaccines ; Myanmar ; Neisseria meningitidis ; Polysaccharide vaccine ; Refugees ; Serogroup ; Surveillance ; Vaccination</subject><ispartof>The Journal of infection, 2020-11, Vol.81 (5), p.698-711</ispartof><rights>2020</rights><rights>Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-b0cce10a7af237e4865decad3b416376a1242adb3210d5cdd3bd9ee7d28ee0b13</citedby><cites>FETCH-LOGICAL-c466t-b0cce10a7af237e4865decad3b416376a1242adb3210d5cdd3bd9ee7d28ee0b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jinf.2020.07.025$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,781,785,3551,27926,27927,45997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32730999$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aye, Aye Mya Min</creatorcontrib><creatorcontrib>Bai, Xilian</creatorcontrib><creatorcontrib>Borrow, Ray</creatorcontrib><creatorcontrib>Bory, Sotharith</creatorcontrib><creatorcontrib>Carlos, Josefina</creatorcontrib><creatorcontrib>Caugant, Dominique A.</creatorcontrib><creatorcontrib>Chiou, Chien-Shun</creatorcontrib><creatorcontrib>Dai, Vo Thi Trang</creatorcontrib><creatorcontrib>Dinleyici, Ener Cagri</creatorcontrib><creatorcontrib>Ghimire, Prakash</creatorcontrib><creatorcontrib>Handryastuti, Setyo</creatorcontrib><creatorcontrib>Heo, Jung Yeon</creatorcontrib><creatorcontrib>Jennison, Amy</creatorcontrib><creatorcontrib>Kamiya, Hajime</creatorcontrib><creatorcontrib>Tonnii Sia, Loong</creatorcontrib><creatorcontrib>Lucidarme, Jay</creatorcontrib><creatorcontrib>Marshall, Helen</creatorcontrib><creatorcontrib>Putri, Nina Dwi</creatorcontrib><creatorcontrib>Saha, Senjuti</creatorcontrib><creatorcontrib>Shao, Zhujun</creatorcontrib><creatorcontrib>Sim, James Heng Chiak</creatorcontrib><creatorcontrib>Smith, Vinny</creatorcontrib><creatorcontrib>Taha, Muhamed-Kheir</creatorcontrib><creatorcontrib>Van Thanh, Phan</creatorcontrib><creatorcontrib>Thisyakorn, Usa</creatorcontrib><creatorcontrib>Tshering, Kinley</creatorcontrib><creatorcontrib>Vázquez, Julio</creatorcontrib><creatorcontrib>Veeraraghavan, Balaji</creatorcontrib><creatorcontrib>Yezli, Saber</creatorcontrib><creatorcontrib>Zhu, Bingqing</creatorcontrib><title>Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative</title><title>The Journal of infection</title><addtitle>J Infect</addtitle><description>•Incidence of meningococcal disease is similar across the Asia–Pacific region.•The most prevalent serogroups of N. meningitidis are B, w and Y, with c also emerging.•Except for China and Australia, vaccination is not included in NIPs across the region.•Antibiotic resistance is an ongoing concern, with non-susceptible strains emerging.•A number of countries have adopted whole genome sequencing in surveillance programs.
The degree of surveillance data and control strategies for invasive meningococcal disease (IMD) varies across the Asia–Pacific region. IMD cases are often reported throughout the region, but the disease is not notifiable in some countries, including Myanmar, Bangladesh and Malaysia. Although there remains a paucity of data from many countries, specific nations have introduced additional surveillance measures. The incidence of IMD is low and similar across the represented countries (<0.2 cases per 100,000 persons per year), with the predominant serogroups of Neisseria meningitidis being B, W and Y, although serogroups A and X are present in some areas. Resistance to ciprofloxacin is also of concern, with the close monitoring of antibiotic-resistant clonal complexes (e.g., cc4821) being a priority. Meningococcal vaccination is only included in a few National Immunization Programs, but is recommended for high-risk groups, including travellers (such as pilgrims) and people with complement deficiencies or human immunodeficiency virus (HIV). Both polysaccharide and conjugate vaccines form part of recommendations. However, cost and misconceptions remain limiting factors in vaccine uptake, despite conjugate vaccines preventing the acquisition of carriage.</description><subject>Antibiotic resistance</subject><subject>Asia - epidemiology</subject><subject>Asia-Pacific</subject><subject>Bacterial meningitis</subject><subject>Bangladesh</subject><subject>Carriage</subject><subject>Conjugate vaccine</subject><subject>Emerging strains</subject><subject>High-risk groups</subject><subject>Humans</subject><subject>Immunization program</subject><subject>Meningococcal disease</subject><subject>Meningococcal Infections - epidemiology</subject><subject>Meningococcal Infections - prevention & control</subject><subject>Meningococcal Vaccines</subject><subject>Myanmar</subject><subject>Neisseria meningitidis</subject><subject>Polysaccharide vaccine</subject><subject>Refugees</subject><subject>Serogroup</subject><subject>Surveillance</subject><subject>Vaccination</subject><issn>0163-4453</issn><issn>1532-2742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1O3DAUhS1UBAPlBbqosoRF0uufxJOqmxECWglEF7C2HPtmeqeZhNqZkdjxDn1DngRHQ5HYdOXF_c6xzsfYJw4FB159WRUr6ttCgIACdAGi3GMzXkqRC63EBzZLkMyVKuUhO4pxBQC1rKsDdiiFllDX9Yz9vsGe-uXgBudsl3mKaCNmcRO2SF1ne4cZ9dn4C7NFJPv89PenddSSywIuaeiz0-n7s6_ZXSKW3dCkkvW7SuppJDvSFj-y_dZ2EU9e32N2f3lxd_49v769-nG-uM6dqqoxb8A55GC1bYXUqOZV6dFZLxuV9ujKcqGE9Y0UHHzpfDr4GlF7MUeEhstjdrrrfQjDnw3G0awpOpzW4LCJJsVrPVelgoSKHerCEGPA1jwEWtvwaDiYSbJZmUmymVYa0CZJTqHPr_2bZo3-LfLPagK-7QBMK7eEwURHmFR6CuhG4wf6X_8L_wqPcw</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Aye, Aye Mya Min</creator><creator>Bai, Xilian</creator><creator>Borrow, Ray</creator><creator>Bory, Sotharith</creator><creator>Carlos, Josefina</creator><creator>Caugant, Dominique A.</creator><creator>Chiou, Chien-Shun</creator><creator>Dai, Vo Thi Trang</creator><creator>Dinleyici, Ener Cagri</creator><creator>Ghimire, Prakash</creator><creator>Handryastuti, Setyo</creator><creator>Heo, Jung Yeon</creator><creator>Jennison, Amy</creator><creator>Kamiya, Hajime</creator><creator>Tonnii Sia, Loong</creator><creator>Lucidarme, Jay</creator><creator>Marshall, Helen</creator><creator>Putri, Nina Dwi</creator><creator>Saha, Senjuti</creator><creator>Shao, Zhujun</creator><creator>Sim, James Heng Chiak</creator><creator>Smith, Vinny</creator><creator>Taha, Muhamed-Kheir</creator><creator>Van Thanh, Phan</creator><creator>Thisyakorn, Usa</creator><creator>Tshering, Kinley</creator><creator>Vázquez, Julio</creator><creator>Veeraraghavan, Balaji</creator><creator>Yezli, Saber</creator><creator>Zhu, Bingqing</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202011</creationdate><title>Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative</title><author>Aye, Aye Mya Min ; Bai, Xilian ; Borrow, Ray ; Bory, Sotharith ; Carlos, Josefina ; Caugant, Dominique A. ; Chiou, Chien-Shun ; Dai, Vo Thi Trang ; Dinleyici, Ener Cagri ; Ghimire, Prakash ; Handryastuti, Setyo ; Heo, Jung Yeon ; Jennison, Amy ; Kamiya, Hajime ; Tonnii Sia, Loong ; Lucidarme, Jay ; Marshall, Helen ; Putri, Nina Dwi ; Saha, Senjuti ; Shao, Zhujun ; Sim, James Heng Chiak ; Smith, Vinny ; Taha, Muhamed-Kheir ; Van Thanh, Phan ; Thisyakorn, Usa ; Tshering, Kinley ; Vázquez, Julio ; Veeraraghavan, Balaji ; Yezli, Saber ; Zhu, Bingqing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-b0cce10a7af237e4865decad3b416376a1242adb3210d5cdd3bd9ee7d28ee0b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibiotic resistance</topic><topic>Asia - epidemiology</topic><topic>Asia-Pacific</topic><topic>Bacterial meningitis</topic><topic>Bangladesh</topic><topic>Carriage</topic><topic>Conjugate vaccine</topic><topic>Emerging strains</topic><topic>High-risk groups</topic><topic>Humans</topic><topic>Immunization program</topic><topic>Meningococcal disease</topic><topic>Meningococcal Infections - epidemiology</topic><topic>Meningococcal Infections - prevention & control</topic><topic>Meningococcal Vaccines</topic><topic>Myanmar</topic><topic>Neisseria meningitidis</topic><topic>Polysaccharide vaccine</topic><topic>Refugees</topic><topic>Serogroup</topic><topic>Surveillance</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aye, Aye Mya Min</creatorcontrib><creatorcontrib>Bai, Xilian</creatorcontrib><creatorcontrib>Borrow, Ray</creatorcontrib><creatorcontrib>Bory, Sotharith</creatorcontrib><creatorcontrib>Carlos, Josefina</creatorcontrib><creatorcontrib>Caugant, Dominique A.</creatorcontrib><creatorcontrib>Chiou, Chien-Shun</creatorcontrib><creatorcontrib>Dai, Vo Thi Trang</creatorcontrib><creatorcontrib>Dinleyici, Ener Cagri</creatorcontrib><creatorcontrib>Ghimire, Prakash</creatorcontrib><creatorcontrib>Handryastuti, Setyo</creatorcontrib><creatorcontrib>Heo, Jung Yeon</creatorcontrib><creatorcontrib>Jennison, Amy</creatorcontrib><creatorcontrib>Kamiya, Hajime</creatorcontrib><creatorcontrib>Tonnii Sia, Loong</creatorcontrib><creatorcontrib>Lucidarme, Jay</creatorcontrib><creatorcontrib>Marshall, Helen</creatorcontrib><creatorcontrib>Putri, Nina Dwi</creatorcontrib><creatorcontrib>Saha, Senjuti</creatorcontrib><creatorcontrib>Shao, Zhujun</creatorcontrib><creatorcontrib>Sim, James Heng Chiak</creatorcontrib><creatorcontrib>Smith, Vinny</creatorcontrib><creatorcontrib>Taha, Muhamed-Kheir</creatorcontrib><creatorcontrib>Van Thanh, Phan</creatorcontrib><creatorcontrib>Thisyakorn, Usa</creatorcontrib><creatorcontrib>Tshering, Kinley</creatorcontrib><creatorcontrib>Vázquez, Julio</creatorcontrib><creatorcontrib>Veeraraghavan, Balaji</creatorcontrib><creatorcontrib>Yezli, Saber</creatorcontrib><creatorcontrib>Zhu, Bingqing</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aye, Aye Mya Min</au><au>Bai, Xilian</au><au>Borrow, Ray</au><au>Bory, Sotharith</au><au>Carlos, Josefina</au><au>Caugant, Dominique A.</au><au>Chiou, Chien-Shun</au><au>Dai, Vo Thi Trang</au><au>Dinleyici, Ener Cagri</au><au>Ghimire, Prakash</au><au>Handryastuti, Setyo</au><au>Heo, Jung Yeon</au><au>Jennison, Amy</au><au>Kamiya, Hajime</au><au>Tonnii Sia, Loong</au><au>Lucidarme, Jay</au><au>Marshall, Helen</au><au>Putri, Nina Dwi</au><au>Saha, Senjuti</au><au>Shao, Zhujun</au><au>Sim, James Heng Chiak</au><au>Smith, Vinny</au><au>Taha, Muhamed-Kheir</au><au>Van Thanh, Phan</au><au>Thisyakorn, Usa</au><au>Tshering, Kinley</au><au>Vázquez, Julio</au><au>Veeraraghavan, Balaji</au><au>Yezli, Saber</au><au>Zhu, Bingqing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative</atitle><jtitle>The Journal of infection</jtitle><addtitle>J Infect</addtitle><date>2020-11</date><risdate>2020</risdate><volume>81</volume><issue>5</issue><spage>698</spage><epage>711</epage><pages>698-711</pages><issn>0163-4453</issn><eissn>1532-2742</eissn><abstract>•Incidence of meningococcal disease is similar across the Asia–Pacific region.•The most prevalent serogroups of N. meningitidis are B, w and Y, with c also emerging.•Except for China and Australia, vaccination is not included in NIPs across the region.•Antibiotic resistance is an ongoing concern, with non-susceptible strains emerging.•A number of countries have adopted whole genome sequencing in surveillance programs.
The degree of surveillance data and control strategies for invasive meningococcal disease (IMD) varies across the Asia–Pacific region. IMD cases are often reported throughout the region, but the disease is not notifiable in some countries, including Myanmar, Bangladesh and Malaysia. Although there remains a paucity of data from many countries, specific nations have introduced additional surveillance measures. The incidence of IMD is low and similar across the represented countries (<0.2 cases per 100,000 persons per year), with the predominant serogroups of Neisseria meningitidis being B, W and Y, although serogroups A and X are present in some areas. Resistance to ciprofloxacin is also of concern, with the close monitoring of antibiotic-resistant clonal complexes (e.g., cc4821) being a priority. Meningococcal vaccination is only included in a few National Immunization Programs, but is recommended for high-risk groups, including travellers (such as pilgrims) and people with complement deficiencies or human immunodeficiency virus (HIV). Both polysaccharide and conjugate vaccines form part of recommendations. However, cost and misconceptions remain limiting factors in vaccine uptake, despite conjugate vaccines preventing the acquisition of carriage.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32730999</pmid><doi>10.1016/j.jinf.2020.07.025</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0163-4453 |
| ispartof | The Journal of infection, 2020-11, Vol.81 (5), p.698-711 |
| issn | 0163-4453 1532-2742 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2429784540 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Antibiotic resistance Asia - epidemiology Asia-Pacific Bacterial meningitis Bangladesh Carriage Conjugate vaccine Emerging strains High-risk groups Humans Immunization program Meningococcal disease Meningococcal Infections - epidemiology Meningococcal Infections - prevention & control Meningococcal Vaccines Myanmar Neisseria meningitidis Polysaccharide vaccine Refugees Serogroup Surveillance Vaccination |
| title | Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T10%3A42%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Meningococcal%20disease%20surveillance%20in%20the%20Asia%E2%80%93Pacific%20region%20(2020):%20The%20global%20meningococcal%20initiative&rft.jtitle=The%20Journal%20of%20infection&rft.au=Aye,%20Aye%20Mya%20Min&rft.date=2020-11&rft.volume=81&rft.issue=5&rft.spage=698&rft.epage=711&rft.pages=698-711&rft.issn=0163-4453&rft.eissn=1532-2742&rft_id=info:doi/10.1016/j.jinf.2020.07.025&rft_dat=%3Cproquest_cross%3E2429784540%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2429784540&rft_id=info:pmid/32730999&rft_els_id=S0163445320305065&rfr_iscdi=true |